Recent Advances in Natural Product Drugs, 2nd Edition

Dear Colleagues,

We are pleased to invite you to contribute an article to a Special Issue of Pharmaceutics—“Recent Advances in Natural Product Drugs, 2nd Edition”.

Natural products represent an area of research which has made tremendous progress in the last two decades, with a substantial increase in natural compounds identified in an increasing number of plant and animal sources, a similar rise in non-clinical testing of natural compounds for a variety of potential therapeutic applications, and a considerable development of clinical trials for natural compounds and combinations thereof. Natural products—in the past, the only available medicines—continue to be the basis for about half of the drugs currently available, either in their natural form or as semi-synthetic derivatives with improved pharmacokinetic, pharmacodynamic, or safety properties. While the number of plant species known today is estimated to be about 400,000, those that have been even cursorily investigated for their phytochemical compositions comprise a minority, which means that this field remains, largely, a terra incognita. Additionally, marine life, other animal organisms, fungi, and microorganisms are also territories of knowledge that remain largely unexplored. This Special Issue aims to report research relevant to this area.

In this Special Issue, original research articles and reviews are welcomed for submission. Research areas may include—but are not limited to—the following: pharmaceutical formulation regarding natural products; nanoparticles; pharmaceutical processes; pharmacogenetics or pharmacogenomics of natural products; pharmacokinetics; pharmacodynamics; biological targets of natural products; computational methods used in evaluating or testing natural compounds. We look forward to receiving your contributions.

Prof. Dr. Robert Ancuceanu
Prof. Dr. Mihaela Dinu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.